Jerel Davis
- SEC CIK
- 0001745958
No open-market purchases or sales filed in the past year.
Current role at each company
- TSBX Turnstone Biologics Corp.Directoras of Aug 8, 2025
- KDNY Chinook Therapeutics, Inc.Directoras of Aug 11, 2023
- LENZ LENZ Therapeutics, Inc.Directoras of Jul 21, 2023
- RPTX Repare Therapeutics Inc.Directoras of Jan 3, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Jerel Davis as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TSBX Turnstone Biologics Corp.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 27, 2023 (view filing) | Jul 25 | 2 days | Jerel DavisDirector, 10% Owner | PPurchase | +225.0K | $12.00 | +$2.70M | New position82.0K after | 4 lots |
KDNY Chinook Therapeutics, Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 19, 2023 (view filing) | Apr 17 | 2 days | Jerel DavisDirector | SSale | −295.8K | $20.75 | −$6.14M | −40.0%443.7K after | |
| Mar 3, 2023 (view filing) | Mar 1 | 2 days | Jerel DavisDirector | SSale | −400.0K | $22.75 | −$9.10M | −65.5%211.0K after | 3 lots |
| Jan 5, 2022 (view filing) | Jan 3 | 2 days | Jerel DavisDirector, 10% Owner | SSale | −1.00M | $16.00 | −$16.0M | −64.4%552.1K after | From original3 lots |
| Aug 31, 2021 (view filing) | Aug 27 | 4 days | Jerel DavisDirector, 10% Owner | SSale | −850.0K | $14.00 | −$11.9M | −56.9%644.1K after | 3 lots |
RPTX Repare Therapeutics Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2022 (view filing) | Dec 9 | 4 days | Jerel DavisDirector | SSale | −250.0K | $16.00 | −$4.00M | −10.7%2.09M after | |
| Jun 7, 2022 (view filing) | Jun 3 | 4 days | Jerel DavisDirector, 10% Owner | SSale | −750.0K | $12.25 | −$9.19M | −87.1%111.5K after | 5 lots |
LENZ LENZ Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2021 (view filing) | Jun 29 | 2 days | Jerel DavisDirector, 10% Owner | PPurchase | +180.0K | $17.00 | +$3.06M | +11.8%1.71M after |